| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.04 | 0.6 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |